As the federal government considers easing restrictions on marijuana, the DEA faces a legal challenge from cannabis-reform advocates who accuse it of improperly influencing a key court hearing.
The DEA is expected to reclassify marijuana as a less dangerous drug, a historic move that would dramatically ease federal restrictions on cannabis.
House lawmakers from both sides of the aisle are urging the DEA to reconsider its decision to make kratom, an herbal supplement, a Schedule I drug because of its potential to help heroin addicts.
The DEA is looking for researchers to grow marijuana in an effort to better understand whether cannabis has medicinal benefits.
